ALGS
Aligos Therapeutics, Inc.Pre-market5.51−0.02 −0.36%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delay
Open
5.47
Prev close
5.53
Day range
5.225.52
52-week range
3.9813.69
Volume
33.97K0.40×
Mkt cap
34.41M
P/E ttm
—
Fwd P/E
-1.05
EPS ttm
-7.41
Div yield
0.00%
Earnings
Aug 6, 2026
From 52w high
−59.75%
ALGS earnings and estimates
ALGS Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 5
Before the open · estimated
EPS consensus
$−2.53
range −3.04 – −2.06
EPS growth vs year ago
+16.8%
year ago −3.04
Revenue consensus
$5.54M
+648.0% vs year ago
Options-implied move
—
no expiry soon after the report
Past 4 reactions
±7.3%
average move · beat 3 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 6, 2026 BMO | −0.14 | −1.24 | +88.73% | $27.78M | +16.2% | +47.7% |
| Mar '26 | May 7, 2026 AMC | −2.21 | −2.25 | +1.63% | $2.83M | +6.8% | +10.9% |
| Dec '25 | Mar 5, 2026 BMO | −1.91 | −2.49 | +23.21% | $169.00K | −2.9% | +10.3% |
| Sep '25 | Nov 6, 2025 BMO | −3.04 | −2.01 | −51.24% | $741.00K | −3.1% | −11.9% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −2.53 | −3.04−2.06 | +16.8% | $5.54M | +648.0% | −2.15 −17.9% | −2.38 −6.3% | 2 / 2 |
| Next quarter Dec 2026 | −1.73 | −2.59−0.69 | +9.6% | $614.29K | +263.5% | −1.89 +8.6% | −2.11 +18.0% | 3 / 1 |
| Current year Dec 2026 | −6.52 | −8.03−4.44 | −166.1% | $35.99M | +1546.5% | −7.12 +8.5% | −8.07 +19.2% | 3 / 2 |
| Next year Dec 2027 | −5.25 | −7.18−2.78 | +19.5% | $4.65M | −87.1% | −4.29 −22.3% | −4.17 −25.7% | 1 / 4 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −2.43 | −2.81−2.06 | 2 | 0 / 0 |
| Dec 2026 | −1.91 | −2.02−1.80 | 2 | 0 / 0 |
| Mar 2027 | −1.64 | −1.79−1.49 | 2 | 0 / 0 |
| Jun 2027 | −1.64 | −1.78−1.50 | 2 | 0 / 0 |
| Sep 2027 | −1.36 | −1.73−0.98 | 2 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −6.81 | −7.41−6.41 | 3 | 0 / 0 |
| Dec 2027 | −5.39 | −6.98−4.02 | 3 | 0 / 0 |
| Dec 2028 | 0.58 | −2.854.01 | 2 | 0 / 0 |
| Dec 2029 | 7.22 | −2.3616.79 | 2 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.